🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single center, pilot study to assess the feasibility...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-31
Trial ID
NCT04757090
Treatments Being Tested
Information about the presence of human epidermal growth factor receptor 2 ...
Status
Completed
Location
University Medical Center
Start Date
2013-03
Trial ID
NCT01832051
Treatments Being Tested
The purpose of the first group (Group 1) was to find the optimal time for t...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-12
Trial ID
NCT02023996
Treatments Being Tested
The investigators investigate whether PET imaging with ⁸⁹Zr-trastuzumab can...
Status
Not Yet Recruiting
Location
The Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2026-09-07
Trial ID
NCT07436858
Treatments Being Tested
Current patient work-up, including conventional imaging and pathological as...
Status
Active Not Recruiting
Location
VU University Medical Center
Start Date
2013-08-30
Trial ID
NCT01957332
Treatments Being Tested
T-DM1 , which is a highly innovative but also expensive antiHER2 agent cons...
Status
Completed
Location
Universitair Ziekenhuis Antwerpen (UZA)
Start Date
2012-05
Trial ID
NCT01565200
Treatments Being Tested
The goal of this clinical trial is to test a new PET tracer in patients wit...
Status
Completed
Location
AmsterdamUMC
Start Date
2023-06-26
Trial ID
NCT05955833
Treatments Being Tested
Our goal is to investigate the use of 89Zr-trastuzumab as a HER2 imaging ag...
Status
Recruiting
Location
The Kirklin Clinic
Start Date
2017-11-21
Trial ID
NCT03321045
Treatments Being Tested
HSP90 inhibition is a potentially new targeted drug modality in the treatme...
Status
Completed
Location
University Medical Center Groningen
Start Date
2010-02
Trial ID
NCT01081600
Treatments Being Tested